- XML news feed, subscribe to the following URL with your RSS client: http://www.asha.net/asha/asha-news.xml
Printer Friendly ViewFor Immediate Release
Friday, February 12, 2010
Contact: Brice Carr
Marketing & Communications Manager
Saddlebred Convention Features O'Connor, USEF Medication Rules, World Equestrian Games
Lexington, Kentucky - The American Saddlebred Horse Association's (ASHA) annual convention presents a special appearance by United States Equestrian Federation (USEF) President (and Olympic Equestrian Gold Medalist) David O'Connor on Saturday, February 20, at the Marriott Griffin Gate Resort and Spa in Lexington, Kentucky. O'Connor will lead a special open forum following the Members' Luncheon on Saturday, to discuss the Federation's new rules on medication, as well as the upcoming World Equestrian Games. He will be joined by a veterinary expert from Hagyard in Lexington, as well as Saddlebred officials who will present plans for the breed's exhibits at the Games. This open forum will give an opportunity for all attendees to participate in a question and answer session with the sport's leaders. At the 2010 USEF annual meeting in Louisville in January, negotiation and cooperation among all breeds and disciplines represented produced an agreement on a landmark equine drug issue-allowing for only one nonsteroidal anti-inflammatory drug (NSAID) to be administered to horses competing in USEF-licensed events. It was recommended and approved by the USEF board of directors that beginning December 1, 2011, exhibitors should be permitted to give only one NSAID, rather than two, to horses in competition, citing the harmful effects overuse of the substances can have on the animal's health and well-being. (GR410.1) In preparation for this change, the USEF board approved an interim rule (GR410.4), which will be in effect from April 1, 2010 through November 30, 2011. Members will be permitted to give two NSAIDs in accordance with current rules regarding the administration of NSAIDs, provided that an NSAID Declaration Form is filed with the show office. Under the current USEF rules, no more than two of the seven approved and quantitatively restricted NSAIDs are permitted in a horse at the time of a USEF licensed competition. The one exception to this rule is that currently phenylbutazone (bute) and flunixin (Banamine) are a forbidden combination, and are never permitted together in the horse at the time of a competition. Visit USEF's website, here and here, for a complete list of rule changes approved at the January USEF Board of Directors meeting.
- You can change the year drop-down box to bring up press releases from that year
- You can type in text in the search box to find a phrase that shows up in a press release title or body text. The text search will only be applied to the current year selection.
- If you have any comments or problems please contact Will Wood Jr
